Where are vaccines developed?
Last Updated 18 May 2022.
74 Vaccines in Phase 3 Clinical Trials
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 37 countries
15 trials in 12 countries
-
Nanogen
Nanocovax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 1 country
-
Anhui Zhifei Longcom
Zifivax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 4 countries
20 trials in 5 countries
-
PT Bio Farma
SARS-CoV-2 Protein Subunit Recombinant Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
Medigen
MVC-COV1901- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 countries
14 trials in 4 countries
-
Razi Vaccine and Serum Research Institute
Razi Cov Pars- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
5 trials in 1 country
-
Livzon Mabpharm Inc
V-01- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 3 countries
-
Laboratorios Hipra SA
COVID-19 vaccine HIPRA- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 4 countries
-
Sanofi/GSK
Recombinant Protein- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 7 countries
-
Jiangsu Rec-Biotechnology Co Ltd
ReCOV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 1 country
-
Sanofi/GSK
SP/GSK subunit B.1.351 vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
1 trial in 1 country
-
Sanofi/GSK
SP/GSK subunit D614 vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
1 trial in 1 country
-
Instituto Finlay de Vacunas Cuba
Soberana Plus- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
5 trials in 1 country
-
Instituto Finlay de Vacunas Cuba
Soberana 02- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 4 countries
4 trials in 2 countries
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 5 countries
2 trials in 1 country
-
Shionogi
S-268019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 2 countries
-
Sinocelltech
SCTV01C- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
12 trials in 2 countries
-
University Medical Center Groningen
AKS-452- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 2 countries
-
Bagheiat-allah University of Medical Sciences
Noora vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
3 trials in 1 country
-
West China Hospital
Recombinant (Sf9 cell)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 4 countries
-
Vector State Research Center of Virology and Biotechnology
EpiVacCorona- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 4 countries
4 trials in 1 country
-
Biological E Limited
Corbevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
7 trials in 1 country
-
Sinocelltech
SCTV01E- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 0 countries
-
Vaxine/CinnaGen Co.
SpikoGen- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
7 trials in 2 countries
-
Center for Genetic Engineering and Biotechnology (CIGB)
Abdala- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 6 countries
5 trials in 1 country
-
Takeda
TAK-019 (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
3 trials in 1 country
-
Clover
SCB-2019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
12 trials in 11 countries
-
Codagenix Inc
COVI-VAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 1 country
-
COVAXX
UB-612- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 2 countries
-
SK Bioscience Co Ltd
GBP510- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 6 countries
-
National Vaccine and Serum Institute
Recombinant SARS-CoV-2 Vaccine (CHO Cell)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
3 trials in 2 countries
-
Medicago
Covifenz- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
6 trials in 6 countries
-
Radboud University
ABNCoV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 2 countries
-
Yantai Patronus Biotech Co Ltd
LYB001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 0 countries
-
AnGes
AG0302-COVID19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
8 trials in 1 country
-
Inovio
INO-4800- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
9 trials in 9 countries
-
Zydus Cadila
ZyCoV-D- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
5 trials in 1 country
-
Moderna
mRNA-1273.213- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
2 trials in 1 country
-
Arcturus Therapeutics Inc
ARCT-154- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 3 countries
-
Walvax
mRNA- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 3 countries
-
Daiichi Sankyo Co Ltd
DS-5670a- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 1 country
-
Moderna
mRNA-1273.617.2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
2 trials in 1 country
-
Moderna
mRNA-1273.211- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 86 countries
63 trials in 22 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
80 trials in 26 countries
-
Pfizer/BioNTech
BNT162b1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 3 countries
-
Moderna
mRNA-1273.529- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
Pfizer/BioNTech
BNT162b2s01- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 2 countries
-
Oxford/AstraZeneca
AZD2816- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
2 trials in 2 countries
-
CanSino
Ad5-nCoV-IH- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
3 trials in 3 countries
-
Gamaleya
Sputnik Light- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 26 countries
6 trials in 2 countries
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
24 trials in 7 countries
-
CanSino
Convidecia- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 10 countries
13 trials in 6 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 140 countries
63 trials in 30 countries
-
Serum Institute of India
Covishield (Oxford/ AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 49 countries
2 trials in 1 country
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 111 countries
23 trials in 23 countries
-
Bharat Biotech
BBV154- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
2 trials in 1 country
-
ReiThera
GRAd-COV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 12 countries
-
Mahidol University
NDV-HXP-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 3 countries
-
Wantai
DelNS1-2019-nCoV-RBD-OPT1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 3 countries
-
Israel Institute for Biological Research (IIBR)
Brilife- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
Organization of Defensive Innovation and Research
FAKHRAVAC (MIVAC)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
3 trials in 1 country
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 14 countries
10 trials in 2 countries
-
Valneva
VLA2101- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
1 trial in 1 country
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 91 countries
29 trials in 12 countries
-
Valneva
VLA2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
6 trials in 3 countries
-
Chinese Academy of Medical Sciences
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
8 trials in 4 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
37 trials in 9 countries
-
Sinopharm (Wuhan)
Inactivated (Vero Cells)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
9 trials in 7 countries
-
Health Institutes of Turkey
Turkovac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
8 trials in 1 country
-
Shifa Pharmed Industrial Co
COVIran Barekat- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
6 trials in 1 country
-
KM Biologics Co Ltd
KD-414- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
Research Institute for Biological Safety Problems (RIBSP)
QazVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
3 trials in 1 country
-
Shenzhen Kangtai Biological Products Co
KCONVAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
7 trials in 1 country
68 Vaccines in Phase 2 Clinical Trials
-
Adimmune Corporation
AdimrSC-2f- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
3 trials in 2 countries
-
Novavax
SII B.1.617.2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Icosavax
IVX-411- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Instituto Finlay de Vacunas Cuba
Soberana 01- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
3 trials in 1 country
-
Kentucky Bioprocessing
KBP-201- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Medigen
MVC-COV1901(Beta)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 1 country
-
Novavax
ICC Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Novavax
SII B.1.351- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Novavax
SII Bivalent- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
EuBiologics Co Ltd
EuCorVac-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Research Institute for Biological Safety Problems
QazCoVac-P- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Shanghai Zerun Biotechnology, Walvax Biotechnology
202-CoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 1 country
-
St. Petersburg Research Institute of Vaccines and Sera
Recombinant subunit vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Tuebingen
CoVac-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
3 trials in 1 country
-
University Medical Center Groningen
AKS-452X- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 1 country
-
University of Saskatchewan
COVAC-2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
5 trials in 1 country
-
Human Stem Cell Institute Russia
Betuvax-CoV-2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Livzon Pharmaceutical Group Inc
V-01-351/V-01D- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 1 country
-
Vector State Research Center of Virology and Biotechnology
Aurora-CoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
Center for Genetic Engineering and Biotechnology (CIGB)
CIGB-669- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Clover
SCB-2020S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 0 countries
-
Biological E Limited
BECOV2B- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Biological E Limited
BECOV2C- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Biological E Limited
BECOV2D- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
VBI Vaccines Inc
VBI-2902a- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
The Scientific and Technological Research Council of Turkey
SARS-CoV-2 VLP Vaccine Alpha Variant- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 1 country
-
The Scientific and Technological Research Council of Turkey
SARS-CoV-2 VLP Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
SpyBiotech
RBD SARS-CoV-2 HBsAg VLP- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
AnGes
AG0301-COVID19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Takis
COVID-eVax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Entos Pharmaceuticals Inc
Covigenix VAX-001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Nykode Therapeutics
VB10.2129- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Nykode Therapeutics
VB10.2210- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
GeneOne Life Science, Inc.
GLS-5310- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 2 countries
-
Elixirgen Therapeutics Inc
EXG-5003- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Pfizer/BioNTech
BNT162b2 (B.1.617.2)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 4 countries
-
EyeGene Inc
EG-COVID-003- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Gennova Biopharmaceuticals Limited
HGCO19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Takeda
TAK-919 (Moderna formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
Stemirna Therapeutics Co Ltd
mRNACOVID-19 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
3 trials in 2 countries
-
Arcturus Therapeutics Inc
ARCT-165- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 2 countries
-
Arcturus Therapeutics Inc
LUNAR-COV19/ARCT-021- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
6 trials in 2 countries
-
AIM Vaccine
LVRNA009- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Pfizer/BioNTech
BNT162c2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Pfizer/BioNTech
BNT162b3- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Providence Therapeutics Holdings Inc.
PTX-COVID19-B- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 2 countries
-
Pfizer/BioNTech
BNT162b2 (B.1.1.7)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 4 countries
-
Pfizer/BioNTech
BNT162a1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
ImmunityBio Inc
AAHI-SC2 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
ImmunityBio Inc
AAHI-SC3 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Chulalongkorn University
ChulaCov19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 1 country
-
Chulalongkorn University
ChulaCov19-BNA159 mRNA Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Pfizer/BioNTech
BNT162b2 (B.1.1.7 + B.1.617.2)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 4 countries
-
Moderna
mRNA-1283.211- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 1 country
-
Moderna
mRNA-1283- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Universitätsklinikum Hamburg-Eppendorf
MVA-SARS-2-ST- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
3 trials in 1 country
-
Biocad
BCD-250- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
ImmunityBio Inc
hAd5-Covid-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
7 trials in 2 countries
-
Shenzhen Geno-Immune Medical Institute
LV-SMENP- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Institute of Vaccines and Medical Biologicals
COVIVAC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 2 countries
-
Vaxart
VXA-CoV2-1.1-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
1 trial in 1 country
-
Gamaleya
Gam-COVID-Vac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 0 countries
-
Cellid Co
AdCLD-CoV19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Aivita Biomedical Inc
AV-COVID-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
4 trials in 2 countries
-
City of Hope Medical Center
COH04S1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Airlangga University
UNAIR Inactivated COVID-19 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Chumakov Center
KoviVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 countries
3 trials in 1 country
-
Laboratorio Avi-Mex
Recombinant NDV Vectored Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
48 Vaccines in Phase 1 Clinical Trials
-
Yisheng Biopharma
PIKA COVID-19 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
SK Bioscience Co Ltd
NBP2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Baiya Phytopharm Co Ltd
Baiya SARS-CoV-2 Vax 2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
PT Bio Farma
SARS-CoV-2 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
VaxForm
CoV2-OGEN1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Emergex Vaccines Holding Ltd
PepGNP-SARSCoV2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
US Army Medical Research and Development Command
SpFN COVID-19 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
OSE Immunotherapeutics
CoVepiT- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Baiya Phytopharm Co Ltd
Baiya SARS-CoV-2 Vax 1 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
University of Melbourne
DoCo-Pro-RBD-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
HK inno.N Corporation
IN-B009- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
University of Saskatchewan
COVAC-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 2 countries
-
Scancell
COVIDITY- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Providence Health & Services
CORVax12- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
The University of Hong Kong
SARS-CoV-2 DNA Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
University of Sydney
COVIGEN- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Imam Abdulrahman Bin Faisal University
Almansour-001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 0 countries
-
Symvivo
bacTRL-Spike- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Jiangsu Rec-Biotechnology
RH109- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 0 countries
-
University of Melbourne
MIPSCo-mRNA-RBD-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
HDT Bio
HDT-301- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Moderna
mRNA-1273.351- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
MRC/UVRI and LSHTM Uganda Research Unit
LNP-nCOV saRNA-02 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Gritstone Bio, Inc.
GRT-R910- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
GlaxoSmithKline
CV2CoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
GlaxoSmithKline
CoV2 SAM (LNP)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
CSPC ZhongQi Pharmaceutical Technology
SYS6006- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
2 trials in 1 country
-
VLP Therapeutics Japan
VLPCOV-01- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
SENAI CIMATEC
HDT-301- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Universitatsklinikum Hamburg-Eppendorf
MVA-SARS-2-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Tetherex Pharmaceuticals Corporation
SC-Ad6-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Vaxart
VXA-CoV2-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
AMMS
Ad5-nCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
NIAID
ChAdV68-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
McMaster University
ChAd-triCoV/Mac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
McMaster University
Ad5-triCoV/Mac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
EnGeneIC
COVID-19-EDV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
CyanVac LLC
CVXGA1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Cellid Co
AdCLD-CoV19-1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
NIAID
SAM-LNP-S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Shenzhen Geno-Immune Medical Institute
Covid-19/aAPC- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
The University of Hong Kong
DelNS1-nCoV-RBD LAIV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Meissa Vaccines Inc
MV-014-212- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Osve Pharmaceutical Company
OSVID-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
The Scientific and Technological Research Council of Turkey
Adjuvanted Inactivated Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
National Research Centre Egypt
Covi Vax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Kocak Farma
Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Eva Pharma
EgyVax Vaccine Candidate- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
9 Vaccines are No Longer Progressing
-
Curevac
CVnCoV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
9 trials in 12 countries
-
Genexine
GX-19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 1 country
-
Merck Sharp & Dohme Corp
V591- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 3 countries
-
Sanofi Pasteur
MRT5500- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Altimmune Inc
AdCOVID- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Imperial
LNP-nCoVsaRNA- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Institut Pasteur
COVID-19-101- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 2 countries
-
Merck Sharp & Dohme Corp
V590- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Queensland
Sclamp- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country